Status:
UNKNOWN
Whole Body Diffusion MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Gastro-intestinal Tumors
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Gastro-intestinal Tumor
Accurate Staging
Eligibility:
All Genders
Phase:
NA
Brief Summary
The aim of the study is to assess the value of whole body diffusion weighted MR imaging (WB-DWI) as a non-invasive method. On one hand for pretreatment lesion detection and post-therapeutic tumor recu...
Eligibility Criteria
Inclusion
- In principle, all patients treated for gastrointestinal tumors will be included (only with the permission (informed consent) of the patient)
Exclusion
- In case of a known contraindication for MRI (eg pacemaker), the patient will not be admitted to the study.
Key Trial Info
Start Date :
November 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2015
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT01224990
Start Date
November 1 2010
End Date
December 1 2015
Last Update
April 10 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Gasthuisberg
Leuven, Leuven, Belgium, 3000